RetinaPharma Technologies

RetinaPharma Technologies is a biotechnology and medical device company focused on the diagnosis and treatment of ophthalmic and neurodegenerative disorders. The company's flagship product, the TonoPach system, is an FDA-cleared handheld device that integrates ultrasonic pachymetry and tonometry to provide more accurate intraocular pressure measurements by accounting for corneal thickness. Beyond its diagnostic platform, RetinaPharma has developed a pipeline of neuroprotective therapies, including nutraceuticals and small molecules, aimed at treating conditions such as glaucoma, macular degeneration, and Parkinson's disease. The company has historically collaborated with BioDelivery Sciences International to leverage cochleate-based drug delivery for its therapeutic candidates.